Machine learning predictions of IgG1 and IgG4 self-association and high-concentration solution properties
To meet the widespread demand for subcutaneous delivery of antibody therapeutics, candidates with low viscosity, high solubility, and/or low aggregation propensity in concentrated formulations must be identified. Moreover, early identification of candidates with low self-association increases the likelihood of success at later stages of the development process. Here, we experimentally profile the self-association behavior of a panel of clinical-stage antibodies as a function of pH, excipient content, and antibody isotype. We find that acidic formulations (pH 5) with proline (200 mM) are most effective at suppressing self-association for both IgG1 and IgG4 variants. Moreover, our self-association measurements are correlated with antibody viscosity measurements and inversely correlated with antibody recovery after their concentration using membrane filters. Notably, we developed interpretable machine learning-based classifier and regressor models for predicting IgG1 and IgG4 self-association and demonstrated that they identify antibodies with favorable high-concentration properties. These findings are expected to improve the antibody development process by facilitating the identification of drug-like molecules during their discovery and optimization.
Authors
- William F. Weiss
- Bryan E. Jones (ORCID: https://orcid.org/0000-0003-4764-6290)
- Peter M. Tessier (ORCID: https://orcid.org/0000-0002-3220-007X)
- Steven R. Cottle
- Ronan M. Kelly
- Hsin-Ting Chen
- Na-Young Kwon
- Chloe N. Brown (ORCID: https://orcid.org/0009-0000-9184-8610)
Institutions
- Eli Lilly (United States) (US)
- University of Michigan (US)
Publication Details
- Journal
- mAbs
- Published
- 2026-05-08
- DOI
- https://doi.org/10.1080/19420862.2026.2663641
- Primary Topic
- Monoclonal and Polyclonal Antibodies Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Eli Lilly and Company